Association between Medication Adherence, Anxiety, and Quality of Life in Pulmonary Tuberculosis Patients: A Cross-Sectional Study
JURNAL FARMASIMED (JFM) · 30.04.2026 · 8 (2) · 1193-1202
DOI: 10.35451/wpk19m04 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift JURNAL FARMASIMED (JFM), online erschienen am 30.04.2026. Verfasst von Gelmeyfia und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-ND 4.0).
Abstract (Originalsprache)
Background
Tuberculosis (TB) remains a major public health problem in Indonesia with a high disease burden. Treatment success is strongly influenced by medication adherence; however, psychological factors such as anxiety and aspects of quality of life often interact in complex ways and have not been extensively examined simultaneously, particularly in primary healthcare settings.
Objective
This study aimed to analyze the relationship between medication adherence, anxiety levels, and quality of life among patients with pulmonary tuberculosis.
Methods
A quantitative analytic study with a cross-sectional design was conducted among 107 pulmonary TB patients using a total sampling technique. Variables were measured using standardized instruments, including the MMAS-8, GAD-7, and WHOQOL-BREF. Data were analyzed using Spearman’s rank correlation test.
Results
Most respondents demonstrated a moderate level of medication adherence (62.6%), with anxiety predominantly at a minimal level (98.1%). Correlation analysis revealed a strong negative relationship between adherence and anxiety (rₛ = −0.729; p < 0.001), indicating that higher adherence is associated with lower anxiety levels. Furthermore, adherence was significantly positively associated with quality of life in the psychological (rₛ = 0.454; p < 0.001), social (rₛ = 0.461; p < 0.001), and environmental domains (rₛ = 0.600; p < 0.001), but not in the physical domain (p = 0.058).
Conclusion
These findings highlight that medication adherence plays an important role not only in clinical outcomes but also in patients’ psychological well-being and quality of life. Integrating adherence-based interventions with psychosocial approaches is essential to improve treatment outcomes holistically.
Zitieren
APA
Gelmeyfia, Afriani, T., & Jannah, M. (2026). Association between Medication Adherence, Anxiety, and Quality of Life in Pulmonary Tuberculosis Patients: A Cross-Sectional Study. JURNAL FARMASIMED (JFM), 8(2), 1193-1202. https://doi.org/10.35451/wpk19m04
Vancouver
Gelmeyfia, Afriani T, Jannah M. Association between Medication Adherence, Anxiety, and Quality of Life in Pulmonary Tuberculosis Patients: A Cross-Sectional Study. JURNAL FARMASIMED (JFM). 2026;8(2):1193-1202. doi:10.35451/wpk19m04
BibTeX
@article{Gelmeyfia2026,
author = {Gelmeyfia and Afriani, Tika and Jannah, Miftahul},
title = {Association between Medication Adherence, Anxiety, and Quality of Life in Pulmonary Tuberculosis Patients: A Cross-Sectional Study},
journal = {JURNAL FARMASIMED (JFM)},
year = {2026},
volume = {8},
number = {2},
pages = {1193--1202},
doi = {10.35451/wpk19m04}
}
EUVIMED